Colgate-Palmolive Company logo

Colgate-Palmolive Company (CL)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
94. 11
+1.44
+1.5539%
After Hours
$
95. 00
+0.89 +0.9457%
70.5B Market Cap
40.3 P/E Ratio
2.08% Div Yield
5.77M Volume
3.21 Eps
$ 92.67
Previous Close
Add Transaction
Day Range
92.93 94.11
Year Range
74.55 99.33
Want to track CL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Colgate-Palmolive stock up premarket after earnings beat estimates

Colgate-Palmolive stock up premarket after earnings beat estimates

Colgate-Palmolive Co.'s stock CL, -0.11% rose 1.1% premarket Friday, after the consumer goods company posted better-than-expected second-quarter earnings and backed its full-year guidance. The company had net income of $1731 million, or 89 cents a share, for the quarter, up from $502 million, or 60 cents a share, in the year-earlier period.

Marketwatch | 2 years ago
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar

These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks | 2 years ago
Will Strong Volume & Pricing Aid Colgate's (CL) Q2 Earnings?

Will Strong Volume & Pricing Aid Colgate's (CL) Q2 Earnings?

Solid volume and pricing, and growth across categories and regions are likely to aid Colgate's (CL) Q2 results. Softness in China, high raw material costs and FX inflation are concerning.

Zacks | 2 years ago
Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 years ago
Colgate-Palmolive (CL) is an Incredible Growth Stock: 3 Reasons Why

Colgate-Palmolive (CL) is an Incredible Growth Stock: 3 Reasons Why

Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 2 years ago
Colgate-Palmolive Company (CL) Hits Fresh High: Is There Still Room to Run?

Colgate-Palmolive Company (CL) Hits Fresh High: Is There Still Room to Run?

Colgate-Palmolive (CL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 2 years ago
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?

Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?

Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 2 years ago
Is ColgatePalmolive (CL) Stock Outpacing Its Consumer Staples Peers This Year?

Is ColgatePalmolive (CL) Stock Outpacing Its Consumer Staples Peers This Year?

Here is how Colgate-Palmolive (CL) and Ollie's Bargain Outlet (OLLI) have performed compared to their sector so far this year.

Zacks | 2 years ago
Why Colgate-Palmolive (CL) is a Great Dividend Stock Right Now

Why Colgate-Palmolive (CL) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes?

Zacks | 2 years ago
Colgate's (CL) Innovation & Pricing Efforts Aid: Apt to Buy?

Colgate's (CL) Innovation & Pricing Efforts Aid: Apt to Buy?

Colgate (CL) benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.

Zacks | 2 years ago
Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings

Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings

Colgate-Palmolive Q2 earnings expectations: asset turnover improvement, margin growth in Hill's Pet Nutrition, balance sheet deleveraging. Asset turnover ratio has improved since the 2019 Filorga acquisition, with sales growth in key regions. Profit margins have shown improvement. We'd like to see further operating margin expansion in Hill's Pet Nutrition.

Seekingalpha | 2 years ago
7 Blue-Chip Cash Cows to Milk for Steady Income

7 Blue-Chip Cash Cows to Milk for Steady Income

When you're still years away from retirement, you want to ramp up your portfolio to target growth-oriented enterprises. At the same time, there's a lot of comfort and confidence in so-called cash cows.

Investorplace | 2 years ago
Loading...
Load More